Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Revenue: 2020-2021

Historic Revenue for Atea Pharmaceuticals (AVIR) over the last 2 years, with Dec 2021 value amounting to $351.4 million.

  • Atea Pharmaceuticals' Revenue was N/A to $192.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $351.4 million, marking a year-over-year change of. This contributed to the annual value of $351.4 million for FY2021, which is 622.49% up from last year.
  • As of FY2021, Atea Pharmaceuticals' Revenue stood at $351.4 million, which was up 622.49% from $48.6 million recorded in FY2020.
  • In the past 5 years, Atea Pharmaceuticals' Revenue registered a high of $351.4 million during FY2021, and its lowest value of $48.6 million during FY2020.
  • In the last 2 years, Atea Pharmaceuticals' Revenue had a median value of $200.0 million in 2020 and averaged $200.0 million.
  • Data for Atea Pharmaceuticals' Revenue shows a peak YoY spiked of 622.49% (in 2021) over the last 5 years.
  • Atea Pharmaceuticals' Revenue (Yearly) stood at $48.6 million in 2020, then surged by 622.49% to $351.4 million in 2021.